STOCK TITAN
  1. Home
  2. Sec-filings
  3. TRBG
  4. [Form 3] Turbogen Ltd. Initial Statement of Beneficial Ownership

Turbogen director holds options for 30,177 shares

Turbogen Ltd. (TRBG) reported that director Shitrit Idan Ben holds options to purchase 30,177 ordinary shares.

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Turbogen Ltd. (TRBG) reported that director Shitrit Idan Ben holds options to purchase 30,177 ordinary shares. These options were granted on March 9, 2025, at an exercise price of $2.99 per share and expire on March 9, 2032.

The grant vests in three equal installments of 33.3% beginning March 9, 2025. As of August 25, 2026, 20,118 options are fully vested, and none have been exercised into ordinary shares.

Positive

  • None.

Negative

  • None.
Insider Shitrit Idan Ben
Role Director
Type Security Shares Price Value
holding Share option (right to buy) F2, F1 -- -- --
Holdings After Transaction: Share option (right to buy) — 30,177 contracts (Direct)
Footnotes (2)
  1. F1. A total of 30,177 options were granted on March 9, 2025 and vest in three equal installments of 33.3% beginning March 9, 2025. As of August 25, 2026, 20,118 options are fully vested and none have been exercised into ordinary shares.
  2. F2. The options were granted with an exercise price of NIS 8.95 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $2.99 per share.
Options granted 30,177 options Total options granted on March 9, 2025 to purchase ordinary shares
Vested options as of August 25, 2026 20,118 options Options that are fully vested as of August 25, 2026
Exercise price $2.99 per share Exercise price converted from NIS using an exchange rate as of August 24, 2026
Original exercise price in NIS NIS 8.95 per share Original option exercise price before conversion to U.S. dollars
Exchange rate used NIS 2.994 to USD $1.00 Rate used to convert the exercise price into U.S. dollars
Option grant date March 9, 2025 Date on which 30,177 options were granted
Option expiration date March 9, 2032 Expiration date of the reported options
Share option (right to buy) financial
"Share option (right to buy)"
exercise price financial
"The options were granted with an exercise price of NIS 8.95 per share."
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vest in three equal installments financial
"A total of 30,177 options were granted on March 9, 2025 and vest in three equal installments"
ordinary shares financial
"none have been exercised into ordinary shares."
Ordinary shares are a type of ownership stake in a company, giving shareholders a right to participate in the company’s profits and decision-making through voting. They are similar to owning a piece of a business, and their value can rise or fall based on the company's performance. Investors buy ordinary shares to potentially earn dividends and benefit from the company's growth over time.
exchange rate financial
"converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00"
Exchange rate is the price of one currency expressed in another—for example, how many euros you receive for one US dollar. It matters to investors because changes in that price alter the reported profits, costs and value of assets for companies and portfolios that operate or hold money across borders; think of it like switching measurement units, where the same item can look bigger or smaller depending on the unit used.

FAQ

What insider holdings did TRBG director Shitrit Idan Ben report?
Shitrit Idan Ben reported holding 30,177 options to purchase Turbogen Ltd. ordinary shares. The options were granted on March 9, 2025, vest in three equal installments of 33.3%, and expire on March 9, 2032. As of August 25, 2026, 20,118 of these options are fully vested.

What is the exercise price of the options held by the TRBG director?
The options held by the director have an exercise price of $2.99 per share. This reflects an original price of NIS 8.95 per share, converted using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026.

How many of the TRBG director’s options are vested and exercisable?
As of August 25, 2026, 20,118 options held by the director are fully vested. The filing states that none of these options have been exercised into ordinary shares as of that date.

When do the reported Turbogen Ltd. options expire?
The options to purchase Turbogen Ltd. ordinary shares expire on March 9, 2032. They were granted on March 9, 2025, and vest in three equal installments of 33.3% beginning on the grant date.

Were any of the TRBG director’s options exercised into shares?
No. The disclosure states that as of August 25, 2026, none of the 30,177 options granted to the director have been exercised into ordinary shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Shitrit Idan Ben
(Last)(First)(Middle)
22 EFAL STREET, KIRYAT ARYEH
(Street)
PETAH TIKVA4951122
(City)(State)(Zip)
ISRAEL
(Country)		2. Date of Event Requiring Statement (Month/Day/Year)
08/28/2026		3. Issuer Name and Ticker or Trading Symbol
Turbogen Ltd. [ TRBG ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Share option (right to buy)03/29/2025(1)03/09/2032Ordinary shares30,177$2.99(2)D
Explanation of Responses:
1. A total of 30,177 options were granted on March 9, 2025 and vest in three equal installments of 33.3% beginning March 9, 2025. As of August 25, 2026, 20,118 options are fully vested and none have been exercised into ordinary shares.
2. The options were granted with an exercise price of NIS 8.95 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 2.994 to USD $1.00 as of August 24, 2026, resulting in an exercise price of $2.99 per share.
/s/ Idan Ben Shitrit08/31/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)

Source: View Original Filing on SEC EDGAR